Viewing Study NCT00635804


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT00635804
Status: COMPLETED
Last Update Posted: 2018-09-05
First Post: 2008-02-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 3281-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators